By Adam Rhodes ( December 7, 2018, 3:53 PM EST) -- Clinical-stage biotechnology company Moderna late Thursday said it raised more than $604 million in an initial public offering touted as the largest biotech IPO ever, alongside another offering that reaped roughly $131 million for cancer and autoimmune disorder-focused Synthorx....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.